Drugs for the treatment of central diabetes insipidus: historical background and modern opportunities | Zendy

Darya Mikhaylova | Zendy; Ekaterina Pigarova | Zendy; Larisa Dzeranova | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Drugs for the treatment of central diabetes insipidus: historical background and modern opportunities

Author(s) -

Darya Mikhaylova,

Ekaterina Pigarova,

Larisa Dzeranova

Publication year - 2017

Publication title -

obesity and metabolism

Language(s) - English

Resource type - Journals

eISSN - 2306-5524

pISSN - 2071-8713

DOI - 10.14341/omet2017117-23

Subject(s) - polyuria , diabetes insipidus , polydipsia , desmopressin , vasopressin , medicine , endocrinology , nasal administration , pediatrics , pharmacology , diabetes mellitus

Central diabetes insipidus is a severe disease with disturbance of arginine vasopressin secretion, which leads to excretion of large amounts of hypotonic urine. The polyuria-polydipsia syndrome is essential as a clinical presentation and high impact condition. Desmopressin, a synthetic analog of arginine vasopressin, is used to compensate a water-electrolyte balance is available in forms of tablets and intranasal spray. Free drug choice is obligated for proper treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research